-
Elon Musk Denies Ketamine Allegations: 'If This BS From NYT Were True, It Would Have Been Extremely Obvious'
Saturday, May 31, 2025 - 12:29pm | 492Elon Musk took to X to criticize a recent New York Times report alleging he frequently used ketamine during the 2024 campaign. What Happened: On Friday, Musk responded to a comment by Pierre Ferragu, who called the New York Times’ piece on Musk “pathetic.” Musk agreed with Ferragu...
-
Ozempic: Unexpected Anti-Aging Miracle Drug? Researchers Reveal Surprising Potential
Saturday, August 31, 2024 - 3:30pm | 534Researchers are now suggesting that a drug for Type 2 diabetes and obesity might actually have anti-aging powers. Harlan Krumholz of the Yale School of Medicine declared that semaglutide, marketed as Ozempic, could be a game-changer with benefits far beyond our wildest dreams after several...
-
EXCLUSIVE: Revolutionary Alzheimer's Drug By IGC Shows Early Success
Wednesday, March 20, 2024 - 2:02pm | 878In a massive stride towards Alzheimer’s treatment, IGC Pharma (NYSE:IGC) recently revealed promising interim results for their pioneering drug, IGC-AD1, aimed at mitigating agitation in Alzheimer’s patients. This breakthrough is a beacon of hope for millions affected by this...
-
Healthcare Advocates United: A Push For Congress To Recognize CBD As Dietary Supplements
Thursday, July 20, 2023 - 2:24pm | 556In the realm of healthcare advocacy, two organizations have joined forces to battle a shared adversary: unregulated CBD. What Happened: "Our utmost goal is to help individuals living with chronic diseases and serious injuries that cause pain improve their quality of life and have better health...
-
Revolutionizing Rheumatoid Arthritis Treatment: Psychedelics Biotech Co. Touts New Patent
Wednesday, June 21, 2023 - 2:21pm | 358Psychedelics-focused biopharmaceutical company Silo Pharma, Inc. (NASDAQ: SILO) announced on Wednesday that the U.S. Patent and Trademark Office has issued Patent 16/825,371 titled "Peptide-Targeted Liposomal Delivery for Treatment, Diagnosis, and Imaging of Diseases and Disorders." The...
-
Top Federal Official: Safe Consumption Sites Save Lives, More Cannabis & Psychedelics Research Needed
Tuesday, November 22, 2022 - 10:08am | 563Safe consumption sites have proven useful in saving patients from overdosing, a top federal drug official said. “Yes, it’s preventing people from dying,” National Institute on Drug Abuse (NIDA) Director Nora Volkow, said at the recent STAT Summit, reported Marijuana Moment....
-
Apple Sidesteps Feds On Weed As Health App Doesn't Discriminate On Legality
Monday, September 19, 2022 - 11:58am | 705With cannabis use becoming widespread, new challenges such as understanding and avoiding possible negative interactions with pharmaceutical drugs are important issues. Apparently, the latest software update from Apple Inc (NASDAQ: AAPL) seeks to clear up those doubts. The iOS...
-
NM Dispensary Can Sell Marijuana Near School, TN Pol Says Weed Is Dangerous, Queen Elizabeth Kiboshes Bermuda's Plans
Wednesday, September 7, 2022 - 12:38pm | 574NM Dispensary Gets Green Light To Sell Marijuana Near School A New Mexico drugstore has got unanimous approval to sell both medical and recreational cannabis even though it's situated near school, reported Las Cruces Sun-News. Las Cruces City Council green-lighted a request for a near-total...
-
Euro Food Agency Concerned About Health Effects Of CBD, Asks For More Research
Friday, June 10, 2022 - 11:55am | 523The European Food Safety Authority (EFSA) is asking for more research on the effects of CBD on humans. The agency issued a statement earlier this week saying that “the safety of CBD as a novel food cannot currently be established,” as available research on the...
-
Benzinga Cannabis Hour Recap: Skye Bioscience CEO Discusses How Cannabinoids May Treat Glaucoma
Thursday, February 11, 2021 - 3:31pm | 527Cannabinoid receptors distributed within the body are part of the endocannabinoid system that largely affects processes such as mood, memory, pain-sensation, and appetite, to name a few. Two types of receptors — CB1 and CB2 — “play a vital role in managing different body...
-
GW Pharmaceuticals Revenue Hits $137M, Tests Another Cannabis Plant-Based Drug
Tuesday, November 3, 2020 - 1:00pm | 402Biopharmaceutical company GW Pharmaceuticals plc (NASDAQ: GWPH) revealed Tuesday that its revenue for the third quarter hit $137.1 million, up by 51% year-over-year. For the first nine months of this fiscal year, total revenue amounted to $378.6 million versus $202.3 million for the...
-
Chan Zuckerberg Initiative Backs Drug Decriminalization In Oregon With $500K
Monday, October 5, 2020 - 1:27pm | 319Facebook Inc. (NASDAQ: FB) chief executive Mark Zuckerberg and his wife Priscilla Chan backed a campaign poised to decriminalize all drugs in Oregon. According to the Marijuana Moment, the Chan Zuckerberg Initiative Advocacy donated $500,000, which accounts for a third of...
-
These Three Speculative Small Caps Are Loved By Insiders and Institutions
Thursday, August 22, 2013 - 11:55am | 354Small-cap pharmaceutical companies are as risky as they come. To combat this, investors look at how insiders and institutions are playing these firms with their significant expertise and inside scoop. Anacor Pharmaceuticals (NASDAQ: ANAC) develops small molecule therapeutics, the majority of...